Basic Information
MENQUADFI SOLUTION FOR INJECTION
INJECTION, SOLUTION
Regulatory Information
SIN16454P
March 29, 2022
Prescription Only
Therapeutic
INTRAMUSCULAR
August 10, 2023
May 30, 2025
XJ07AH08
Company Information
Active Ingredients
Strength: 55 mcg/ 0.5 mL
Strength: 10 mcg/ 0.5 mL
Strength: 10 mcg/ 0.5 mL
Strength: 10 mcg/ 0.5 mL
Strength: 10 mcg / 0.5mL
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to the active substances or to any of the excipients listed in section List of excipients or after previous administration of the vaccine or a vaccine containing the same components – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
Indication Information
**Therapeutic indications** MenQuadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by _Neisseria meningitidis_ serogroups A, C, W, and Y. The use of this vaccine should be in accordance with available official recommendations.